4//SEC Filing
Portnoy Mark L. 4
Accession 0001209191-21-071279
CIK 0000862692other
Filed
Dec 26, 7:00 PM ET
Accepted
Dec 27, 5:00 PM ET
Size
14.9 KB
Accession
0001209191-21-071279
Insider Transaction Report
Form 4
Portnoy Mark L.
DirectorCo-CEO10% Owner
Transactions
- Award
Stock Option
2021-12-22$12.27/sh+100,000$1,227,000→ 100,000 totalExercise: $12.27From: 2021-12-22Exp: 2028-12-21→ Common Stock (100,000 underlying) - Award
Stock Option
2021-12-22$12.27/sh+20,000$245,400→ 20,000 totalExercise: $12.27From: 2021-12-22Exp: 2024-12-21→ Common Stock (20,000 underlying)
Holdings
- 762,514
Common Stock
- 22,222
Stock Option
Exercise: $7.53From: 2019-08-30Exp: 2029-08-30→ Common Stock (22,222 underlying) - 71,529(indirect: By Partnership)
Common Stock
- 20,000
Stock Option
Exercise: $7.92From: 2018-03-08Exp: 2028-03-08→ Common Stock (20,000 underlying) - 59,459
Stock Option
Exercise: $3.14From: 2016-04-15Exp: 2026-04-15→ Common Stock (59,459 underlying) - 42,266(indirect: By 401(k))
Common Stock
- 20,000
Stock Option
Exercise: $7.28From: 2019-12-20Exp: 2029-12-20→ Common Stock (20,000 underlying)
Footnotes (4)
- [F1]Shares of Common Stock held by Capital Asset Fund #1 Limited Partnership, as to which Mark L. Portnoy may be deemed the beneficial owner as its general partner.
- [F2]Stock options will vest 1/3 on the date of grant, 1/3 on December 1, 2020 and 1/3 on December 1, 2021.
- [F3]Stock options fully vest upon issuance.
- [F4]Stock options vest immediately if the price of the Company's stock reaches $25.00 per share during the seven-year option term.
Documents
Issuer
CRYO CELL INTERNATIONAL INC
CIK 0000862692
Entity typeother
Related Parties
1- filerCIK 0001529249
Filing Metadata
- Form type
- 4
- Filed
- Dec 26, 7:00 PM ET
- Accepted
- Dec 27, 5:00 PM ET
- Size
- 14.9 KB